Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Minimal Residual Disease in AML: Why Has It Lagged Behind Pediatric ALL?
Elisabeth Paietta
Oncology
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Minimal Residual Disease in AML: Why Has It Lagged Behind Pediatric ALL?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Residual Neoplasm
100%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
92%
Acute Myeloid Leukemia
89%
Pediatrics
60%
Therapeutics
7%